In vitro cytotoxicity of Emblica officinalis against different human cancer cell lines

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue SUPPL 2, 2012, Pages 77-78

  Verma, Satish K ^a   Shaban, Asima ^a   Nautiyal, Rajesh ^a   Purohit, Reena ^b   Singh, Santosh ^c   Chimata, Madhvi Lata ^d  

^a KLPG college Naini Allahabad   (India)

^b Dept of Biotechnology SIPAS Dehradun ^*  (India)

^c JNPG College   (India)

^d Dept of Biotechnology   (India)

Author keywords

Cytotoxicity test; Emblica officinalis; Human cancer cell lines; In vitro; SRB

Indexed keywords

ALCOHOL; EMBLICA OFFICINALIS EXTRACT; SULFORHODAMINE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL STRAIN A549; CELL STRAIN HT29; CELL STRAIN IMR 32; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; EMBLICA OFFICINALIS; HEP 2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY;

EID: 84862729249     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Antarkar, D.S., Ashok, B.V., Doshi, J.C., Athavale, A.V., Vinchoo, K.S., Natekar, M.R., Thathed, P.S., Ramesh, V., Kale, N., 1980. Double-bind clinical trial of Arogyawardhani-an ayurvedicdrug in acute viral hepatitis. Indian Journal of Medical Research 72, 588-593.
2. Asmawi, M.Z., Kankaanranta, H., Moilanen, E., Vapaatalo, H., 1993. Anti-inflammatory activities of Emblica officinalis Gaertn. leaf extracts. Journal of Pharmacy and Pharmacology 45, 581-584
3. De, S., Ravishankar, B., Bhavsar, G.C., 1993. Plants with hepatoprotective activity a review. Indian Drugs 30, 355-363.
4. Dhir, H., Roy, R.K., Sharma, A., Talukdar, G., 1990. Modification of clastogenicity of lead and aluminium in mouse bone marrow.
5. Jeena, K.J., Joy, K.L., Kuttan, R., 1999. Effect of Emblica officinalis Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Letters 116, 11-16.
6. Jeena, K.J., Kuttan, G., Josely, G., Kuttan, R., 1997. Antimutagenicand anticarcinogenic activity of Emblica officinalis Gaertn. Journal of Clinical Biochemistry and Nutrition 22, 171-176 cells by dietary ingestion of Phyllanthus emblica fruit extract. Mutation Research 241, 305-312.4
7. Jeena, K.J., Kuttan, R., 1995. Antioxidant activity of Emblica officinalis. Nadkarni, A.K., 1952. Dr K.M. Nadkarni's Indian Materia Medica, Popular Book Depot, Mumbai, Dootpapeshwar Prakashan Ltd., Panvel. vol. 2., p. 34.
8. Monks, Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines, J Natl. Cancer Institute 83 (1991) 757-766.
9. Ojha, J.K., 1988. Chyavanaprash, a Scientific Study, first ed. Tara Book Agency, Varanasi, p. 53. Journal of Clinical Biochemistry and Nutrition 19, 63-70.
10. P. Skehan, New colorimetric cytotoxicity assay for anticancer drug screening, Journal of National Cancer Institute 82 (1990) 1107-1112.
11. Satish K. Verma, Santosh K. Singh, Shivsharan Singh and Abhishek Mathur, In vitro cytotoxicity of Cannabis sativa and Trigonella foenum graecum against human cancer cell lines, Journal of Chemical and Pharmaceutical Research 2010, 2 (4): 861-865.
12. Satish Kumar Verma, Santosh Kumar Singh, Abhishek Mathur and Shivsharan Singh. In vitro cytotoxicity of Argemone mexicana against different human cancer cell lines. International Journal of Chemical, Environmental and Pharmaceutical Research, 1(1): 37-39, (2010).